These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 22241668)
1. Risk of cancer in patients with inflammatory bowel disease and venous thromboembolism: a nationwide cohort study. Sørensen GV; Erichsen R; Svaerke C; Farkas DK; Sørensen HT Inflamm Bowel Dis; 2012 Oct; 18(10):1859-63. PubMed ID: 22241668 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period. Hansen AT; Erichsen R; Horváth-Puhó E; Sørensen HT J Thromb Haemost; 2017 Apr; 15(4):702-708. PubMed ID: 28135041 [TBL] [Abstract][Full Text] [Related]
3. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Kappelman MD; Farkas DK; Long MD; Erichsen R; Sandler RS; Sørensen HT; Baron JA Clin Gastroenterol Hepatol; 2014 Feb; 12(2):265-73.e1. PubMed ID: 23602821 [TBL] [Abstract][Full Text] [Related]
4. Increased Cancer Risk in Patients with Kidney Disease and Venous Thromboembolism: A Population-Based Cohort Study. Rønnow Sand J; Troelsen FS; Nagy D; Farkas DK; Erichsen R; Christiansen CF; Sørensen HT Thromb Haemost; 2023 Dec; 123(12):1165-1176. PubMed ID: 36574778 [TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in a high-incidence population-based cohort of Faroese patients with inflammatory bowel disease from 1960 to 2020 - a Faroese IBD cohort study. Midjord J; Nielsen KR; Vang AG; Strøm M; Lophaven S; Hammer T; Burisch J Scand J Gastroenterol; 2024 Jun; 59(6):661-668. PubMed ID: 38407208 [TBL] [Abstract][Full Text] [Related]
6. Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort. Rifkin AS; Shi Z; Wei J; Zheng SL; Helfand BT; Cordova JS; Biank VF; Tafur AJ; Khan O; Xu J World J Gastroenterol; 2023 Oct; 29(39):5494-5502. PubMed ID: 37900992 [TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism and risk of cancer in patients with rheumatoid arthritis. Pedersen AB; Vandenbroucke J; Horváth-Puhó E; Sørensen HT J Thromb Haemost; 2017 Dec; 15(12):2325-2332. PubMed ID: 28913891 [TBL] [Abstract][Full Text] [Related]
9. Timing and Location of Venous Thromboembolisms After Surgery for Inflammatory Bowel Disease. McKenna NP; Bews KA; Behm KT; Mathis KL; Cima RR; Habermann EB J Surg Res; 2024 Apr; 296():563-570. PubMed ID: 38340490 [TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data. Merola JF; Ertmer B; Liang H; Yue X; Ofori S; Krueger W J Am Acad Dermatol; 2024 May; 90(5):935-944. PubMed ID: 38147900 [TBL] [Abstract][Full Text] [Related]
12. Long-term risk of venous thromboembolism among patients with gastrointestinal non-neoplastic and neoplastic diseases: A prospective cohort study of 484 211 individuals. Yuan S; Sun Y; Chen J; Li X; Larsson SC Am J Hematol; 2024 Feb; 99(2):172-181. PubMed ID: 37753710 [TBL] [Abstract][Full Text] [Related]
13. The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort. Gade IL; Braekkan SK; Naess IA; Hansen JB; Cannegieter SC; Overvad K; Jensvoll H; Hammerstrøm J; Blix K; Tjønneland A; Kristensen SR; Severinsen MT J Thromb Haemost; 2017 Aug; 15(8):1567-1575. PubMed ID: 28585779 [TBL] [Abstract][Full Text] [Related]
14. Risk of Venous Thromboembolism in Patients With Stage III and IV Non-Small-Cell Lung Cancer: Nationwide Descriptive Cohort Study. Ording AG; Christensen TD; Skjøth F; Noble S; Højen AA; Mørkved AL; Larsen TB; Petersen RH; Meldgaard P; Jakobsen E; Søgaard M Clin Lung Cancer; 2024 Jul; 25(5):407-416.e1. PubMed ID: 38705834 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Risk of VTE in Sarcoidosis: A Nationwide Cohort Study. Yafasova A; Fosbøl EL; Gustafsson F; Krintel SB; Kristensen SL; Schou M; Petersen JK; Sun G; Rossing K; Doi SN; Køber L; Butt JH Chest; 2024 Jul; 166(1):136-145. PubMed ID: 38295951 [TBL] [Abstract][Full Text] [Related]
17. A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan. Ando K; Fujiya M; Watanabe K; Hiraoka S; Shiga H; Tanaka S; Iijima H; Mizushima T; Kobayashi T; Nagahori M; Ikeuchi H; Kato S; Torisu T; Kobayashi K; Higashiyama M; Fukui T; Kagaya T; Esaki M; Yanai S; Abukawa D; Naganuma M; Motoya S; Saruta M; Bamba S; Sasaki M; Uchiyama K; Fukuda K; Suzuki H; Nakase H; Shimizu T; Iizuka M; Watanabe M; Suzuki Y; Hisamatsu T J Gastroenterol; 2021 Dec; 56(12):1062-1079. PubMed ID: 34611740 [TBL] [Abstract][Full Text] [Related]
18. Parental history and venous thromboembolism: a nationwide study of age-specific and sex-specific familial risks in Sweden. Zöller B; Li X; Sundquist J; Sundquist K J Thromb Haemost; 2011 Jan; 9(1):64-70. PubMed ID: 20942849 [TBL] [Abstract][Full Text] [Related]
19. Venous Thromboembolism Among Patients With Inflammatory Bowel Diseases is Not Related to Increased Thrombophilia: A Case-Control Study. Ollech JE; Waizbard A; Lubetsky A; Kopylov U; Goren I; Dotan I; Yanai H J Clin Gastroenterol; 2022 Mar; 56(3):e222-e226. PubMed ID: 34231498 [TBL] [Abstract][Full Text] [Related]